Oregon Medicaid looks at restricting access to expensive new hepatitis C drug
July 31, 2014 at 22:09 PM EDT
An Oregon Medicaid committee on Thursday significantly scaled back access to an effective — but expensive — new drug used to treat hepatitis C.
